Covid-19 Vaccine IP Waiver Will Benefit Foreign Rivals Like China, Critics Warn

“There is absolutely no need or compelling rationale” for the IP waiver, according to Stephen Ezell, vice president at the Information Technology and Innovation Foundation, a technology think tank.

Once a country forces the disclosure of know-how, there would be no control over who has access to it, he told The Epoch Times.

This will not only affect the COVID-19 vaccines, but also non-COVID-related drugs and therapies using mRNA technology.

“What’s absurd is their assertion that such a waiver wouldn’t lead to China getting their hands on technologies innovative companies have invested billions to develop; and instead of China getting through stealing it, our own government would be complicit in compelling its handover,” Ezell said.